TRIL

Trillium Therapeutics Inc.
TRIL

Delisted

TRIL was delisted on the 16th of November, 2021.

2 hedge funds and large institutions have $18K invested in Trillium Therapeutics Inc. in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 177 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
ST
151
Sphinx Trading
Illinois
FIA
152
FNY Investment Advisers
New York
BPGAM
153
BTG Pactual Global Asset Management
Bermuda
WAM
154
Weiss Asset Management
Massachusetts
SAM
155
Shell Asset Management
Netherlands
AIP
156
Ameritas Investment Partners
Nebraska
QT
157
Quantbot Technologies
New York
Walleye Trading
158
Walleye Trading
New York
CG
159
Cutler Group
California
Wells Fargo
160
Wells Fargo
California
FF
161
FourThought Financial
Florida
PFGIA
162
Patriot Financial Group Insurance Agency
Massachusetts
HI
163
Harbour Investments
Wisconsin
UBS Group
164
UBS Group
Switzerland
QCG
165
Quadrant Capital Group
Ohio
SIS
166
Sound Income Strategies
Florida
PCM
167
PenderFund Capital Management
British Columbia, Canada
TWA
168
TCI Wealth Advisors
Arizona
Rockefeller Capital Management
169
Rockefeller Capital Management
New York
TCWM
170
Total Clarity Wealth Management
Illinois
SMG
171
Spectrum Management Group
Indiana
LC
172
Lindbrook Capital
California
PWM
173
Prentice Wealth Management
New York
BAM
174
Bellevue Asset Management
Washington
CAPTRUST Financial Advisors
175
CAPTRUST Financial Advisors
North Carolina